Which has higher earnings and valuation, DRIO or OPRX?

OptimizeRx has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DarioHealth $22.36M 2.83 -$41.71M -$6.13 N/A OptimizeRx $109.43M 1.48 $5.13M $0.23 37.26

Is DRIO or OPRX more profitable?

OptimizeRx has a net margin of 4.66% compared to DarioHealth's net margin of -169.87%. OptimizeRx's return on equity of 9.44% beat DarioHealth's return on equity. Company Net Margins Return on Equity Return on Assets DarioHealth -169.87% -54.81% -33.36% OptimizeRx 4.66% 9.44% 7.11%

Do analysts rate DRIO or CCLD?

DarioHealth presently has a consensus target price of $10.00, suggesting a potential upside of 54.80%. Given DarioHealth's higher probable upside, research analysts plainly believe DarioHealth is more favorable than CareCloud. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DarioHealth 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 CareCloud 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has better earnings & valuation, DRIO or CCLD?

CareCloud has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DarioHealth $22.36M 2.83 -$41.71M -$6.13 N/A CareCloud $120.50M 0.71 $10.80M $0.07 28.86

Is DRIO or CCLD more profitable?

CareCloud has a net margin of 6.21% compared to DarioHealth's net margin of -169.87%. CareCloud's return on equity of 27.07% beat DarioHealth's return on equity. Company Net Margins Return on Equity Return on Assets DarioHealth -169.87% -54.81% -33.36% CareCloud 6.21% 27.07% 14.56%

DarioHealth (DRIO) Competitors

$6.46 +0.30 (+4.87%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$6.44 -0.01 (-0.23%)

As of 10/2/2026 07:47 PM Eastern

Compare

DRIO vs. AMWL, OPRX, HCAT, DH, and CCLD

Should you buy DarioHealth stock or one of its competitors? DarioHealth's main competitors and comparable companies include American Well (AMWL), OptimizeRx (OPRX), Health Catalyst (HCAT), Definitive Healthcare (DH), and CareCloud (CCLD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does DarioHealth compare to American Well?

DarioHealth (NASDAQ:DRIO) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 3.5% of DarioHealth shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

DarioHealth has higher earnings, but lower revenue than American Well. American Well is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	2.83	-$41.71M	-$6.13	N/A
American Well	$249.32M	0.82	-$95.70M	-$4.77	N/A

In the previous week, DarioHealth's average media sentiment score of 0.00 equaled American Well'saverage media sentiment score.

Company	Overall Sentiment
DarioHealth	Neutral
American Well	Neutral

DarioHealth has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, American Well has a beta of 1.67, meaning that its stock price is 67% more volatile than the broader market.

DarioHealth presently has a consensus price target of $10.00, indicating a potential upside of 54.80%. American Well has a consensus price target of $9.50, indicating a potential downside of 22.80%. Given DarioHealth's stronger consensus rating and higher probable upside, equities analysts plainly believe DarioHealth is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

American Well has a net margin of -35.75% compared to DarioHealth's net margin of -169.87%. American Well's return on equity of -30.12% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
American Well	-35.75%	-30.12%	-22.30%

Summary

American Well beats DarioHealth on 8 of the 14 factors compared between the two stocks.

How does DarioHealth compare to OptimizeRx?

DarioHealth (NASDAQ:DRIO) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

DarioHealth currently has a consensus target price of $10.00, indicating a potential upside of 54.80%. OptimizeRx has a consensus target price of $11.57, indicating a potential upside of 35.02%. Given DarioHealth's higher probable upside, analysts plainly believe DarioHealth is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

DarioHealth has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

In the previous week, OptimizeRx had 4 more articles in the media than DarioHealth. MarketBeat recorded 4 mentions for OptimizeRx and 0 mentions for DarioHealth. OptimizeRx's average media sentiment score of 0.25 beat DarioHealth's score of 0.00 indicating that OptimizeRx is being referred to more favorably in the news media.

Company	Overall Sentiment
DarioHealth	Neutral
OptimizeRx	Neutral

OptimizeRx has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	2.83	-$41.71M	-$6.13	N/A
OptimizeRx	$109.43M	1.48	$5.13M	$0.23	37.26

OptimizeRx has a net margin of 4.66% compared to DarioHealth's net margin of -169.87%. OptimizeRx's return on equity of 9.44% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
OptimizeRx	4.66%	9.44%	7.11%

Summary

OptimizeRx beats DarioHealth on 14 of the 16 factors compared between the two stocks.

How does DarioHealth compare to Health Catalyst?

DarioHealth (NASDAQ:DRIO) and Health Catalyst (NASDAQ:HCAT) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

In the previous week, Health Catalyst had 3 more articles in the media than DarioHealth. MarketBeat recorded 3 mentions for Health Catalyst and 0 mentions for DarioHealth. Health Catalyst's average media sentiment score of 0.45 beat DarioHealth's score of 0.00 indicating that Health Catalyst is being referred to more favorably in the news media.

Company	Overall Sentiment
DarioHealth	Neutral
Health Catalyst	Neutral

DarioHealth has higher earnings, but lower revenue than Health Catalyst. DarioHealth is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	2.83	-$41.71M	-$6.13	N/A
Health Catalyst	$311.14M	0.42	-$177.97M	-$3.68	N/A

DarioHealth has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market.

Health Catalyst has a net margin of -90.61% compared to DarioHealth's net margin of -169.87%. Health Catalyst's return on equity of -1.83% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
Health Catalyst	-90.61%	-1.83%	-0.80%

DarioHealth presently has a consensus price target of $10.00, indicating a potential upside of 54.80%. Health Catalyst has a consensus price target of $2.45, indicating a potential upside of 40.00%. Given DarioHealth's stronger consensus rating and higher possible upside, equities analysts clearly believe DarioHealth is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Health Catalyst	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 3.5% of DarioHealth shares are held by insiders. Comparatively, 19.4% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Health Catalyst beats DarioHealth on 12 of the 16 factors compared between the two stocks.

How does DarioHealth compare to Definitive Healthcare?

DarioHealth (NASDAQ:DRIO) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

DarioHealth has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market.

DarioHealth has higher earnings, but lower revenue than Definitive Healthcare. DarioHealth is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	2.83	-$41.71M	-$6.13	N/A
Definitive Healthcare	$241.52M	0.41	-$138.93M	-$1.60	N/A

In the previous week, Definitive Healthcare had 3 more articles in the media than DarioHealth. MarketBeat recorded 3 mentions for Definitive Healthcare and 0 mentions for DarioHealth. DarioHealth's average media sentiment score of 0.00 equaled Definitive Healthcare'saverage media sentiment score.

Company	Overall Sentiment
DarioHealth	Neutral
Definitive Healthcare	Neutral

DarioHealth currently has a consensus target price of $10.00, indicating a potential upside of 54.80%. Definitive Healthcare has a consensus target price of $1.47, indicating a potential upside of 57.66%. Given Definitive Healthcare's higher probable upside, analysts plainly believe Definitive Healthcare is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90

Definitive Healthcare has a net margin of -72.28% compared to DarioHealth's net margin of -169.87%. Definitive Healthcare's return on equity of 3.55% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
Definitive Healthcare	-72.28%	3.55%	1.63%

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Definitive Healthcare beats DarioHealth on 12 of the 16 factors compared between the two stocks.

How does DarioHealth compare to CareCloud?

DarioHealth (NASDAQ:DRIO) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

In the previous week, CareCloud had 3 more articles in the media than DarioHealth. MarketBeat recorded 3 mentions for CareCloud and 0 mentions for DarioHealth. CareCloud's average media sentiment score of 0.23 beat DarioHealth's score of 0.00 indicating that CareCloud is being referred to more favorably in the news media.

Company	Overall Sentiment
DarioHealth	Neutral
CareCloud	Neutral

DarioHealth presently has a consensus target price of $10.00, suggesting a potential upside of 54.80%. Given DarioHealth's higher probable upside, research analysts plainly believe DarioHealth is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
CareCloud	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

CareCloud has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	2.83	-$41.71M	-$6.13	N/A
CareCloud	$120.50M	0.71	$10.80M	$0.07	28.86

33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 3.5% of DarioHealth shares are owned by company insiders. Comparatively, 14.8% of CareCloud shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

CareCloud has a net margin of 6.21% compared to DarioHealth's net margin of -169.87%. CareCloud's return on equity of 27.07% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
CareCloud	6.21%	27.07%	14.56%

DarioHealth has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market.

Summary

CareCloud beats DarioHealth on 12 of the 16 factors compared between the two stocks.

Get DarioHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DRIO vs. The Competition

Export

Metric	DarioHealth	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$60.37M	$1.78B	$7.14B	$13.17B
Dividend Yield	N/A	3.95%	2.53%	16.78%
P/E Ratio	-1.05	21.02	275.68	26.04
Price / Sales	2.83	87.61	658.29	101.16
Price / Cash	N/A	31.91	77.60	51.75
Price / Book	0.64	6.16	10.93	6.31
Net Income	-$41.71M	-$18.66M	$3.51B	$362.16M
7 Day Performance	-2.56%	-2.24%	-2.00%	-1.66%
1 Month Performance	-7.45%	-1.62%	-6.15%	-4.50%
1 Year Performance	-60.49%	-21.59%	7.44%	2.06%

DarioHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DRIO DarioHealth	3.4195 of 5 stars	$6.46 +4.9%	$10.00 +54.8%	-62.6%	$60.37M	$22.36M	N/A	165
AMWL American Well	1.4465 of 5 stars	$13.16 -0.4%	$9.50 -27.8%	+101.6%	$217.77M	$249.32M	N/A	562
OPRX OptimizeRx	4.3232 of 5 stars	$7.60 -0.3%	$11.43 +50.4%	-51.3%	$143.18M	$109.43M	33.04	105	Analyst Forecast
HCAT Health Catalyst	3.8509 of 5 stars	$1.72 -9.0%	$2.45 +42.4%	-37.5%	$129.45M	$311.14M	N/A	1,200	Positive News
DH Definitive Healthcare	2.8513 of 5 stars	$1.01 +13.5%	$1.47 +45.7%	-72.0%	$107.82M	$241.52M	N/A	686

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DRIO) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DarioHealth (DRIO) Competitors

DRIO vs. AMWL, OPRX, HCAT, DH, and CCLD

How does DarioHealth compare to American Well?

Summary

How does DarioHealth compare to OptimizeRx?

Summary

How does DarioHealth compare to Health Catalyst?

Summary

How does DarioHealth compare to Definitive Healthcare?

Summary

How does DarioHealth compare to CareCloud?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DRIO vs. The Competition

DarioHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DarioHealth (DRIO) Competitors

DRIO vs. AMWL, OPRX, HCAT, DH, and CCLD

How does DarioHealth compare to American Well?

Do institutionals & insiders believe in DRIO or AMWL?

Which has better valuation and earnings, DRIO or AMWL?

Does the media favor DRIO or AMWL?

Which has more volatility and risk, DRIO or AMWL?

Do analysts recommend DRIO or AMWL?

Is DRIO or AMWL more profitable?

Summary

How does DarioHealth compare to OptimizeRx?

Do institutionals and insiders believe in DRIO or OPRX?

Do analysts rate DRIO or OPRX?

Which has more volatility and risk, DRIO or OPRX?

Does the media favor DRIO or OPRX?

Which has higher earnings and valuation, DRIO or OPRX?

Is DRIO or OPRX more profitable?

Summary

How does DarioHealth compare to Health Catalyst?

Does the media favor DRIO or HCAT?

Which has preferable valuation and earnings, DRIO or HCAT?

Which has more risk & volatility, DRIO or HCAT?

Is DRIO or HCAT more profitable?

Do analysts rate DRIO or HCAT?

Do insiders and institutionals believe in DRIO or HCAT?

Summary

How does DarioHealth compare to Definitive Healthcare?

Which has more risk and volatility, DRIO or DH?

Which has stronger earnings & valuation, DRIO or DH?

Does the media favor DRIO or DH?

Do analysts rate DRIO or DH?

Is DRIO or DH more profitable?

Do insiders & institutionals believe in DRIO or DH?

Summary

How does DarioHealth compare to CareCloud?

Does the media refer more to DRIO or CCLD?

Do analysts rate DRIO or CCLD?

Which has better earnings & valuation, DRIO or CCLD?

Do insiders and institutionals hold more shares of DRIO or CCLD?

Is DRIO or CCLD more profitable?

Which has more risk & volatility, DRIO or CCLD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DRIO vs. The Competition

DarioHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools